319 related articles for article (PubMed ID: 32153500)
1. Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem Cells.
Würth R; Thellung S; Corsaro A; Barbieri F; Florio T
Front Endocrinol (Lausanne); 2020; 11():54. PubMed ID: 32153500
[TBL] [Abstract][Full Text] [Related]
2. Evidence of brain tumor stem progenitor-like cells with low proliferative capacity in human benign pituitary adenoma.
Chen L; Ye H; Wang X; Tang X; Mao Y; Zhao Y; Wu Z; Mao XO; Xie L; Jin K; Yao Y
Cancer Lett; 2014 Jul; 349(1):61-6. PubMed ID: 24732807
[TBL] [Abstract][Full Text] [Related]
3. The identification of human pituitary adenoma-initiating cells.
Manoranjan B; Mahendram S; Almenawer SA; Venugopal C; McFarlane N; Hallett R; Vijayakumar T; Algird A; Murty NK; Sommer DD; Provias JP; Reddy K; Singh SK
Acta Neuropathol Commun; 2016 Nov; 4(1):125. PubMed ID: 27894339
[TBL] [Abstract][Full Text] [Related]
4. Pituitary tumors contain a side population with tumor stem cell-associated characteristics.
Mertens F; Gremeaux L; Chen J; Fu Q; Willems C; Roose H; Govaere O; Roskams T; Cristina C; Becú-Villalobos D; Jorissen M; Poorten VV; Bex M; van Loon J; Vankelecom H
Endocr Relat Cancer; 2015 Aug; 22(4):481-504. PubMed ID: 25921430
[TBL] [Abstract][Full Text] [Related]
5. Isolation of tumour stem-like cells from benign tumours.
Xu Q; Yuan X; Tunici P; Liu G; Fan X; Xu M; Hu J; Hwang JY; Farkas DL; Black KL; Yu JS
Br J Cancer; 2009 Jul; 101(2):303-11. PubMed ID: 19568241
[TBL] [Abstract][Full Text] [Related]
6. Pituitary adenomas, stem cells, and cancer stem cells: what's new?
Caffarini M; Orciani M; Trementino L; Di Primio R; Arnaldi G
J Endocrinol Invest; 2018 Jul; 41(7):745-753. PubMed ID: 29222642
[TBL] [Abstract][Full Text] [Related]
7. Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas.
Würth R; Barbieri F; Pattarozzi A; Gaudenzi G; Gatto F; Fiaschi P; Ravetti JL; Zona G; Daga A; Persani L; Ferone D; Vitale G; Florio T
Mol Neurobiol; 2017 Sep; 54(7):4879-4895. PubMed ID: 27514754
[TBL] [Abstract][Full Text] [Related]
8. Stem cells and their role in pituitary tumorigenesis.
Carreno G; Gonzalez-Meljem JM; Haston S; Martinez-Barbera JP
Mol Cell Endocrinol; 2017 Apr; 445():27-34. PubMed ID: 27720895
[TBL] [Abstract][Full Text] [Related]
9. Pituitary adenoma pathogenesis: an update.
Rostad S
Curr Opin Endocrinol Diabetes Obes; 2012 Aug; 19(4):322-7. PubMed ID: 22617628
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome analysis of MENX-associated rat pituitary adenomas identifies novel molecular mechanisms involved in the pathogenesis of human pituitary gonadotroph adenomas.
Lee M; Marinoni I; Irmler M; Psaras T; Honegger JB; Beschorner R; Anastasov N; Beckers J; Theodoropoulou M; Roncaroli F; Pellegata NS
Acta Neuropathol; 2013 Jul; 126(1):137-50. PubMed ID: 23756599
[TBL] [Abstract][Full Text] [Related]
11. The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas.
Dai C; Liang S; Sun B; Kang J
Front Endocrinol (Lausanne); 2020; 11():608422. PubMed ID: 33362722
[TBL] [Abstract][Full Text] [Related]
12. Adult pituitary stem cells: from pituitary plasticity to adenoma development.
Florio T
Neuroendocrinology; 2011; 94(4):265-77. PubMed ID: 22116388
[TBL] [Abstract][Full Text] [Related]
13. Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors.
Peverelli E; Giardino E; Treppiedi D; Meregalli M; Belicchi M; Vaira V; Corbetta S; Verdelli C; Verrua E; Serban AL; Locatelli M; Carrabba G; Gaudenzi G; Malchiodi E; Cassinelli L; Lania AG; Ferrero S; Bosari S; Vitale G; Torrente Y; Spada A; Mantovani G
Int J Cancer; 2017 Apr; 140(8):1870-1880. PubMed ID: 28120505
[TBL] [Abstract][Full Text] [Related]
14. Ectopic pituitary adenoma with malignant transformation.
Hosaka N; Kitajiri S; Hiraumi H; Nogaki H; Toki J; Yang G; Hisha H; Ikehara S
Am J Surg Pathol; 2002 Aug; 26(8):1078-82. PubMed ID: 12170097
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Associated Macrophages: New Horizons for Pituitary Adenoma Researches.
Han C; Lin S; Lu X; Xue L; Wu ZB
Front Endocrinol (Lausanne); 2021; 12():785050. PubMed ID: 34925244
[TBL] [Abstract][Full Text] [Related]
16. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[TBL] [Abstract][Full Text] [Related]
17. Overview of the 2017 WHO Classification of Pituitary Tumors.
Mete O; Lopes MB
Endocr Pathol; 2017 Sep; 28(3):228-243. PubMed ID: 28766057
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas.
Dogansen SC; Yalin GY; Tanrikulu S; Tekin S; Nizam N; Bilgic B; Sencer S; Yarman S
Pituitary; 2018 Aug; 21(4):347-354. PubMed ID: 29460202
[TBL] [Abstract][Full Text] [Related]
19. [Intracranial metastasis of pituitary adenoma: a case report].
Taya K; Terao T; Nakazaki H; Sawauchi S; Numoto RT; Murakami S; Yamaguchi Y; Hashimoto T; Abe T
No Shinkei Geka; 2004 Mar; 32(3):279-84. PubMed ID: 15148803
[TBL] [Abstract][Full Text] [Related]
20. Treatment of pituitary carcinomas and atypical pituitary adenomas: a review.
Hirohata T; Ishii Y; Matsuno A
Neurol Med Chir (Tokyo); 2014; 54(12):966-73. PubMed ID: 25446382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
